Recruiting NA Musculoskeletal Injuries

New treatment option for Musculoskeletal Injuries

Official title Combined Effects of Calisthenics and Plyometric to Reduce Risk of Musculoskeletal Injuries Among School Going Children

ClinicalTrials.gov ID: NCT06732687

What this study is testing

What it's testing
The goal of this clinical trial is to know about the combined effects of calisthenics and plyometric exercises on reducing risk of MSK injuries among school-going children. The main questions it aims to answer are: 1.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 8 to 12, men only. Healthy volunteers may be eligible.

You may be able to join if

  • Male School Going Children (8-12 Years Of Age)
  • Normal BMI of School Going Children
  • No Recent Musculoskeletal Injury from last month.
  • Not Actively Engaged In Other Sports

You likely can't join if

  • Children with any mental or physical disability.
  • Children with acute illness or fracture
  • Active Inflammation or infections
  • Any physical deformity

The study team makes the final eligibility decision.

Where it's taking place

  • Rawalpindi, Punjab Province, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling male, 8 years to 12 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.